Advanced search
Publication Cover
Scandinavian Journal of Urology and Nephrology Volume 18, 1984 - Issue sup79: Scandinavian Symposium on the Physiology and Clinical Use of Ace Inhibitors
Submit an article Journal homepage
7
Views
23
CrossRef citations to date
0
Altmetric
Session III: Antihypertensive Treatment with ACE Inhibitors

Enalapril and Lisinopril in Renovascular Hypertension Antihypertensne and Hormonal Effects of Two New Angio-Tensin-Converting-Enzyme (ACE) Inhibitors

A Preliminary Report

Bengt E KarlbergHypertension-Endocrine Unit, University Hospital, Helsinki, Finland
,
Frej FyhrquistUniversity Hospital, Linköping, Sweden and IV Medical Clinic, Helsinki, Finland
,
Carola Grönhagen-RiskaUniversity Hospital, Linköping, Sweden and IV Medical Clinic, Helsinki, Finland
,
Ilkka TikkanenUniversity Hospital, Linköping, Sweden and IV Medical Clinic, Helsinki, Finland
&
K Peter ÖhmanHypertension-Endocrine Unit, University Hospital, Helsinki, Finland
Pages 103-106 | Published online: 27 Oct 2016

References

  • Atkinson A.B., Brown J.J., Cumming A.M.M., Fraser R., Lever A.F., Leckie B.J., Morton J.J., Robertson J.I.S., Davies D.L.: Captopril in the management of hypertension with renal artery stenosis: its long-term effect as a predictor of surgical outcome. Am. J. Cardiol 49: 1460–6, 1982.
  • Hodsman G.P., Brown J.J., Davies D.L., Fraser R., Lever A.p., Morton J.J., Murray G.D., Robertson J.I.S.: Converting enzyme inhibitor enalapril(MK 421) in treatment of hypertension with renal artery stenosis. Br. Med. J. 285:1697–9, 1982.
  • Ferguson R.K., Vlasses P.H., Swanson B.N., Mojaverian P., Hichens M., Irvin J.D., Huber P.B.: Effects of enalapril, a new convening enzyme inhibitor, in hypertension. Clin. Pharmacol. Ther. 32(1): 48–13, 1982.
  • Brunner D.B., Desponds G., Biollaz J., Keller I., Ferber F., Gavras H., Brunner H.R., Schelling J. L.: Effect of a new angiotensin converting enzyme inhibitor MK-421 and its lysine analogue on the components of the renin system in healthy subjects. Br. J. Clin. Pharmacol 11(5): 461–7, 1981.
  • Fyhrquist F., Soveri P., Puutula L., Stenman U.H.: Radioimmunoassay of plasma renin activity. Clin. Chem. 22:250–6, 1976.
  • Kappelgaard A.M., Damkjaer Nielsen M, Giese J.: Measurement of angiotensin II in human plasma: Technical modifications and practical experience. Clin. Chim. Acta 67: 299–306, 1976.
  • Tolagen K., Karlberg B.E.: Plasma and urinary aldosterone and their interrelations with blood pressure, plasma renin activity and urinary electrolytes in normotensive subjects. Scand. J. Clin. Invest 38: 241–6, 1978.
  • Fyhrquist F., Tikkanen I., Grönhagen-Riska C., Hording L., Hichens M.: Inhibitor binding assay for angiotensin converting enzyme. Clin. Chem. 30(5): 696–700, 1984.
  • Gomez H.J., Cirillo V.J., Jones K.H.: The clinical pharmacology of enalapril. J. Hypertension 1 (suppl): 65–70, 1981
  • Millar J.A., Derkx F.H.M., McLean K., ReidJ.L.: Pharmacodynamics of converting enzyme inhibition: the cardiovascu1ar, endocrine and autonomic effects of MK 421 and MK 521. Br. J. Clin. Pharmacol 14:347–55, 1982.
  • Gavras H., Waeber B., Gavras I., Biollaz J., Brunner H.R., Davies R.O.: Antihypertensive effect of the new oral converting enzyme inhibitor “MK 421”. Lancet 2: 543–6, 198l.
  • De Leeuw P.W., Hoogma R.P.L.M., Van Soest G.A.W., Tchang P.T., Birkenhäger W.H.: Humoral and renal effectS, of MK-421 (enalapril) in hypertensive subjects. Journal of Cardiovasc. Pharmacol. 5: 731–6, 1983.
  • Hodsman G.P., Zabludowski J.R., Zoccali C, Fraser R., Morton J.J., Murray G.D., Robertson J.I.S.: Enalapril (MK 421) and its lysine analogue (MK 521): A comparison of acute and chronic effects on blood pressure, renin-angiotensin system and sodium excretion in normal man. Br. J. Clin. Pharmacol. 17: 233–41, 1984.
  • Rotmensch H.H., Vlasses P.H., Swanson B.N., Irwin J.P., Harris K.H., Merrill D.G., Ferguson R.K.: Antihypertensive efficacy of once daily MK-521, a new nonsulfhydryl angiotensin–converting enzyme inhibitor. Am. J. Cardiol. 53: 116–9, 1984.
  • Hodsman G.P., Isles C.G., Murray G.D., Usherwood T.P., Webb D.J., Robertson J.I.S.: Factors related to first dose hypotensive effect of captopril: prediction and treatment Br. Med. J. 286: 832–4, 1983.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.